Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

498
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
498
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

429
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
429
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

71
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
71
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

194
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
194
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

126
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
126

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Covariate hypothesis tests for the cure rate in mixture cure models based on martingale difference correlation.

Statistical methods in medical research·2026
Same author

Modelling dependent censoring in time-to-event data using boosting copula regression.

Lifetime data analysis·2025
Same author

Testing for the Functional Form of a Continuous Covariate in the Shared-Parameter Joint Model.

Statistics in medicine·2025
Same author

Testing for Sufficient Follow-Up in Censored Survival Data by Using Extremes.

Biometrical journal. Biometrische Zeitschrift·2024
Same author

A test for comparing conditional ROC curves with multidimensional covariates.

Journal of applied statistics·2024
Same author

Discussion on "Instrumented difference-in-differences" by Ting Ye, Ashkan Ertefaie, James Flory, Sean Hennessy, and Dylan S. Small.

Biometrics·2022

相关实验视频

Updated: Jul 1, 2025

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.3K

在半参数 AFT 混合治愈模型中的变量选择上.

Motahareh Parsa1, Seyed Mahmood Taghavi-Shahri2, Ingrid Van Keilegom3

  • 1ORSTAT, KU Leuven, Naamsestraat 69, box 3500, 3000, Leuven, Belgium. motahareh.parsa@gmail.com.

Lifetime data analysis
|March 4, 2024
PubMed
概括

这项研究引入了一种新的可变选择方法,用于在生存分析中的混合疗法模型. 适应性LASSO方法准确地确定了未治愈患者治愈和生存的可能性的重要预测因素.

关键词:
加速失效时间加速失效时间适应性激光 (Lasso) 是一种适应性激光.治愈分数的治疗方法混合治愈模型的混合治愈模型受到惩罚的可能性.半参数估计估计的方法

更多相关视频

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.5K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

相关实验视频

Last Updated: Jul 1, 2025

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.3K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.5K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

科学领域:

  • 生物统计学 生物统计学
  • 生存分析的分析.
  • 临床研究方法论 临床研究方法论

背景情况:

  • 临床研究经常涉及时间到事件的数据,有正确的审查,并且有一部分患者从未经历过该事件.
  • 在生存分析中治疗模型对于处理此类数据至关重要,混合治疗模型特别有用.
  • 混合治愈模型允许分别对被治愈的概率 (发生率) 和未治愈个体的生存率 (延迟) 进行建模.

研究的目的:

  • 为混合治愈模型的发病率和延迟组件开发一个强大的变量选择程序.
  • 应用惩罚性概率方法,特别是适应性LASSO,以解决复杂生存数据中的变量选择.
  • 通过广泛的模拟和现实世界的临床数据集来评估拟议方法的性能.

主要方法:

  • 使用混合治愈模型,结合发病率的后勤模型和延迟的半参数加速失效时间模型.
  • 适应性 LASSO 处罚用于发生率和延迟部分的变量选择.
  • 考虑了两个不同的算法来优化处罚概率标准函数.

主要成果:

  • 拟议的变量选择程序在确定治疗概率和生存率的相关预测因素方面表现得准确.
  • 模拟研究证实了在混合治愈模型中适应性LASSO方法的可靠性和有效性.
  • 该方法成功应用于心力衰竭患者的数据集,提供了对影响结果的因素的见解.

结论:

  • 开发的变量选择方法提供了一个强大的工具,用于分析时间到事件数据的治疗分数.
  • 这种方法提高了对影响治疗可能性和未治愈个体生存经验的因素的理解.
  • 这些发现对临床研究具有重大意义,特别是在诸如心脏病学等领域,治疗模型是相关的.